Invesco Pharmaceuticals ETF (NYSEARCA:PJP) Short Interest Up 481.9% in January

Invesco Pharmaceuticals ETF (NYSEARCA:PJP) was the recipient of a large growth in short interest in the month of January. As of January 15th, there was short interest totaling 40,386 shares, a growth of 481.9% from the December 31st total of 6,940 shares. Based on an average daily trading volume, of 141,970 shares, the short-interest ratio is currently 0.3 days. Approximately 1.1% of the company’s stock are short sold. Approximately 1.1% of the company’s stock are short sold. Based on an average daily trading volume, of 141,970 shares, the short-interest ratio is currently 0.3 days.

Institutional Investors Weigh In On Invesco Pharmaceuticals ETF

Institutional investors have recently modified their holdings of the business. Jones Financial Companies Lllp lifted its holdings in shares of Invesco Pharmaceuticals ETF by 11.6% in the 1st quarter. Jones Financial Companies Lllp now owns 2,428 shares of the company’s stock worth $210,000 after purchasing an additional 252 shares during the last quarter. Trilogy Capital Inc. acquired a new position in Invesco Pharmaceuticals ETF during the 2nd quarter worth $1,330,000. DHJJ Financial Advisors Ltd. acquired a new position in shares of Invesco Pharmaceuticals ETF during the second quarter valued at $28,000. Envestnet Asset Management Inc. lifted its holdings in Invesco Pharmaceuticals ETF by 5.6% in the second quarter. Envestnet Asset Management Inc. now owns 19,547 shares of the company’s stock worth $1,561,000 after purchasing an additional 1,040 shares during the period. Finally, AE Wealth Management LLC grew its position in Invesco Pharmaceuticals ETF by 21.5% in the 2nd quarter. AE Wealth Management LLC now owns 717 shares of the company’s stock valued at $57,000 after buying an additional 127 shares in the last quarter.

Invesco Pharmaceuticals ETF Price Performance

NYSEARCA PJP opened at $106.11 on Wednesday. The company has a market capitalization of $398.97 million, a price-to-earnings ratio of 15.59 and a beta of 0.50. The company’s fifty day moving average price is $105.48 and its two-hundred day moving average price is $96.39. Invesco Pharmaceuticals ETF has a 12 month low of $72.25 and a 12 month high of $108.40.

About Invesco Pharmaceuticals ETF

PowerShares Dynamic Pharmaceuticals Portfolio (the Fund) is a non-diversified fund. The Fund seeks investment results that correspond generally to the price and yield of the Dynamic Pharmaceuticals Intellidex Index (the Index). The Index evaluates companies based on a variety of investment merit criteria, including fundamental growth, stock valuation, investment timeliness and risk factors. The Index consists of stocks of 30 United States pharmaceutical companies. These are companies that are principally engaged in the research, development, manufacture, sale or distribution of pharmaceuticals and drugs of all types.